Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-118-0 | CAS number: 25584-83-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: other routes
Administrative data
- Endpoint:
- acute toxicity: other routes
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study meets generally accepted scientific standards with restrictions due to the limited documentation in the summary report
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 974
- Report date:
- 1974
- Reference Type:
- other: company data
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
- Principles of method if other than guideline:
- BASF-Test
Aqueous preparations of the test substance were injected into the peritoneal cavity of the mice. Group-wise documentation of clinical signs was performed over the 7-day study period. Body weight was determined before the start of the study only, as it was needed for determination of dose. The clinical signs and findings were reported in summary form - GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Acrylic acid, monoester with propane-1,2-diol
- EC Number:
- 247-118-0
- EC Name:
- Acrylic acid, monoester with propane-1,2-diol
- Cas Number:
- 25584-83-2
- Molecular formula:
- C6H10O3
- IUPAC Name:
- Reaction mass of 2-hydroxy-1-methylethyl acrylate and 2-hydroxypropyl acrylate
- Details on test material:
- - Name of test material (as cited in study report): Hydroxypropyl acrylate
- Analytical purity: approx. 99 %
- Composition of test material, percentage of components: 66 % 2-Hydroxy-1-propyl acrylate, 33 % 1-Hydroxy-2-propyl acrylate, approx. 1 % free acrylic acid
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: no data
- Mean weight at study initiation: 21.6 g (males and females)
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- water
- Details on exposure:
- VEHICLE
- Concentration in vehicle: 2, 4, 8, and 16 % (v/v)
MAXIMUM DOSE VOLUME APPLIED: 0.26 mL/animal - Doses:
- 200, 400, 500, 800, and 1600 µL/kg bw (corresponding to 210.8, 421.6, 527.0, 843.2, and 1686.4 mg/kg bw)
Recalculation based on density = 1.054 g/mL at 20 °C - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 7 days
Cageside observations were performed several times on the day of administration and daily on workdays during observation period. Body weights were determined at test start and termination.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross-pathological investigation - Statistics:
- On the basis of the observed lethality, the LD50 value was estimated or determined using a graphical evaluation of the dose response curve on probability paper.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 474 mg/kg bw
- Mortality:
- At the highest dose, all animals died within 24 hrs after administration. At 843.2 and 527.0 mg/kg bw 8/10, and 6/10 animals died within 24, and 48 hr, respectively. At the two lower doses, no mortality was observed.
- Clinical signs:
- The clinical signs observed were dyspnoea, saltatory spasms, tremor, twitching, staggering, lateral-abdominal position, slight atony, apathy, in some cases salivation (described as watery secretion from the oral cavity), narcotic-like state, eyelids glued together up to complete eyelid closure.
- Body weight:
- Normal body weight development
- Gross pathology:
- Deceased and sacrificed animals:
No abnormalities observed.
Any other information on results incl. tables
Original value: LGD50 = approx. 450 µL/kg bw
Recalculation based on density = 1.054 g/mL at 20 °C
Mortality:
Dose [mg/kg bw] |
Conc. [%] |
No. of animals/sex |
Dead animals / treated animals after |
|||
|
|
|
1 h |
24 h |
48 h |
7 d |
1686.4 |
16 |
5 m |
0/5 |
5/5 |
5/5 |
5/5 |
5 f |
0/5 |
5/5 |
5/5 |
5/5 |
||
843.2 |
8 |
5 m |
0/5 |
3/5 |
3/5 |
3/5 |
5 f |
0/5 |
5/5 |
5/5 |
5/5 |
||
527.0 |
8 |
5 m |
0/5 |
0/5 |
3/5 |
3/5 |
5 f |
0/5 |
2/5 |
3/5 |
3/5 |
||
421.6 |
4 |
5 m |
0/5 |
0/5 |
0/5 |
0/5 |
5 f |
0/5 |
0/5 |
0/5 |
0/5 |
||
210.8 |
2 |
5 m |
0/5 |
0/5 |
0/5 |
0/5 |
5 f |
0/5 |
0/5 |
0/5 |
0/5 |
m: male
f: female
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
